Symbols / HLN Stock $9.53 +1.82% Haleon plc

Healthcare • Drug Manufacturers - Specialty & Generic • United Kingdom • NYQ
HLN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
About

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Stock Fundamentals
Scroll to Statements
Market Cap 42.40B Enterprise Value 90.72B Income 1.67B Sales 11.03B Book/sh 4.98 Cash/sh 0.15
Dividend Yield 2.04% Payout 37.08% Employees 24535 IPO P/E 19.06 Forward P/E 15.70
PEG 2.44 P/S 3.84 P/B 1.91 P/C EV/EBITDA 33.08 EV/Sales 8.22
Quick Ratio 0.68 Current Ratio 0.92 Debt/Eq 52.37 LT Debt/Eq EPS (ttm) 0.50 EPS next Y 0.61
EPS Growth 92.00% Revenue Growth 0.60% Earnings 2026-02-25 ROA 4.67% ROE 10.27% ROIC
Gross Margin 64.77% Oper. Margin 23.17% Profit Margin 15.11% Shs Outstand 4.45B Shs Float 8.86B Short Float 0.43%
Short Ratio 2.14 Short Interest 52W High 11.42 52W Low 8.71 Beta 0.33 Avg Volume 8.19M
Volume 6.82M Target Price $11.81 Recom Buy Prev Close $9.36 Price $9.53 Change 1.82%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$11.81
Mean price target
2. Current target
$9.53
Latest analyst target
3. DCF / Fair value
$5.66
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$9.53
Low
$10.00
High
$13.92
Mean
$11.81

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-23 up Barclays Equal-Weight → Overweight
2025-09-16 down Barclays Overweight → Equal-Weight
2024-09-20 main Morgan Stanley Overweight → Overweight $11
2024-03-26 main Argus Research Buy → Buy $10
2023-11-01 init Morgan Stanley — → Overweight $9
2023-04-06 up Argus Research Hold → Buy $10
2022-09-28 init Argus Research — → Hold
2022-07-29 init Deutsche Bank — → Hold
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-09-23 McNamara (Brian) 2,027 $9.00 $18,243
2025-09-23 Wellington Management Group LLP 122,938
2025-08-19 Wellington Management Group LLP 7,489
2025-08-06 Wellington Management Group LLP 801,491
2025-07-10 Wellington Management Group LLP 2,387,284
2025-06-10 McNamara (Brian) 3,639 $10.87 $39,555
2025-03-19 Wellington Management Group LLP 56,333
2025-03-14 Paley (Lisa) 289,881
2025-03-14 Paley (Lisa) 135,511 $10.15 $1,375,436
2025-02-24 Pfizer Inc. 197,228,952
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
11,030.00
-1.81%
11,233.00
-0.61%
11,302.00
+4.09%
10,858.00
Operating Revenue
11,030.00
-1.81%
11,233.00
-0.61%
11,302.00
+4.09%
10,858.00
Cost Of Revenue
3,950.00
-10.41%
4,409.00
-3.21%
4,555.00
+6.40%
4,281.00
Reconciled Cost Of Revenue
3,950.00
-10.41%
4,409.00
-3.21%
4,555.00
+6.40%
4,281.00
Gross Profit
7,080.00
+3.75%
6,824.00
+1.14%
6,747.00
+2.58%
6,577.00
Operating Expense
4,668.00
+1.08%
4,618.00
-2.80%
4,751.00
-0.02%
4,752.00
Research And Development
316.00
+6.04%
298.00
-4.18%
311.00
+3.67%
300.00
Selling General And Administration
4,364.00
-1.98%
4,452.00
+0.88%
4,413.00
-1.56%
4,483.00
General And Administrative Expense
4,364.00
-1.98%
4,452.00
+0.88%
4,413.00
-1.56%
4,483.00
Other Operating Expenses
-12.00
+90.91%
-132.00
-588.89%
27.00
+187.10%
-31.00
Total Expenses
8,618.00
-4.53%
9,027.00
-3.00%
9,306.00
+3.02%
9,033.00
Operating Income
2,412.00
+9.34%
2,206.00
+10.52%
1,996.00
+9.37%
1,825.00
Total Operating Income As Reported
2,412.00
+9.34%
2,206.00
+10.52%
1,996.00
+9.37%
1,825.00
EBITDA
2,859.00
+8.79%
2,628.00
+11.78%
2,351.00
+7.70%
2,183.00
Normalized EBITDA
2,814.00
+8.86%
2,585.00
+11.47%
2,319.00
+6.87%
2,170.00
Reconciled Depreciation
360.00
+11.11%
324.00
+4.85%
309.00
+7.67%
287.00
EBIT
2,499.00
+8.46%
2,304.00
+12.83%
2,042.00
+7.70%
1,896.00
Total Unusual Items
45.00
+4.65%
43.00
+34.38%
32.00
+146.15%
13.00
Total Unusual Items Excluding Goodwill
45.00
+4.65%
43.00
+34.38%
32.00
+146.15%
13.00
Special Income Charges
52.00
+842.86%
-7.00
-106.31%
111.00
+153.37%
-208.00
Other Special Charges
-52.00
-842.86%
7.00
+106.31%
-111.00
-153.37%
208.00
Net Income
1,667.00
+15.60%
1,442.00
+37.46%
1,049.00
-1.04%
1,060.00
Pretax Income
2,152.00
+12.67%
1,910.00
+17.32%
1,628.00
+0.62%
1,618.00
Net Non Operating Interest Income Expense
-305.00
+10.03%
-339.00
+15.25%
-400.00
-81.82%
-220.00
Interest Expense Non Operating
347.00
-11.93%
394.00
-4.83%
414.00
+48.92%
278.00
Net Interest Income
-305.00
+10.03%
-339.00
+15.25%
-400.00
-81.82%
-220.00
Interest Expense
347.00
-11.93%
394.00
-4.83%
414.00
+48.92%
278.00
Interest Income Non Operating
57.00
-12.31%
65.00
+160.00%
25.00
-59.68%
62.00
Interest Income
57.00
-12.31%
65.00
+160.00%
25.00
-59.68%
62.00
Tax Provision
472.00
+8.51%
435.00
-15.86%
517.00
+3.61%
499.00
Tax Rate For Calcs
0.00
-3.70%
0.00
-28.38%
0.00
+3.11%
0.00
Tax Effect Of Unusual Items
9.87
+0.78%
9.79
-3.76%
10.18
+153.81%
4.01
Net Income Including Noncontrolling Interests
1,680.00
+13.90%
1,475.00
+32.76%
1,111.00
-0.71%
1,119.00
Net Income From Continuing Operation Net Minority Interest
1,667.00
+15.60%
1,442.00
+37.46%
1,049.00
-1.04%
1,060.00
Net Income From Continuing And Discontinued Operation
1,667.00
+15.60%
1,442.00
+37.46%
1,049.00
-1.04%
1,060.00
Net Income Continuous Operations
1,680.00
+13.90%
1,475.00
+32.76%
1,111.00
-0.71%
1,119.00
Minority Interests
-13.00
+60.61%
-33.00
+46.77%
-62.00
-5.08%
-59.00
Normalized Income
1,631.87
+15.83%
1,408.79
+37.15%
1,027.18
-2.27%
1,051.01
Net Income Common Stockholders
1,667.00
+15.60%
1,442.00
+37.46%
1,049.00
-1.04%
1,060.00
Otherunder Preferred Stock Dividend
0.00
0.00
0.00
0.00
Diluted EPS
0.37
+17.83%
0.31
+38.94%
0.23
-1.74%
0.23
Basic EPS
0.37
+17.72%
0.32
+38.60%
0.23
-0.87%
0.23
Basic Average Shares
4,491.00
-1.58%
4,563.29
-0.82%
4,600.88
-0.36%
4,617.50
Diluted Average Shares
4,513.00
-1.73%
4,592.36
-1.06%
4,641.59
+0.52%
4,617.50
Diluted NI Availto Com Stockholders
1,667.00
+15.60%
1,442.00
+37.46%
1,049.00
-1.04%
1,060.00
Total Other Finance Cost
15.00
+50.00%
10.00
-9.09%
11.00
+175.00%
4.00
Line Item Trend 2025-12-31
Total Assets
32,630.00
Current Assets
4,550.00
Cash Cash Equivalents And Short Term Investments
1,260.00
Cash And Cash Equivalents
1,260.00
Cash Equivalents
Cash Financial
1,260.00
Other Short Term Investments
Receivables
Accounts Receivable
1,642.00
Gross Accounts Receivable
1,684.00
Allowance For Doubtful Accounts Receivable
-42.00
Other Receivables
287.00
Taxes Receivable
194.00
Accrued Interest Receivable
Loans Receivable
Inventory
1,025.00
Raw Materials
242.00
Work In Process
7.00
Finished Goods
776.00
Prepaid Assets
Restricted Cash
64.00
Assets Held For Sale Current
Hedging Assets Current
78.00
Total Non Current Assets
28,080.00
Net PPE
1,997.00
Gross PPE
3,561.00
Accumulated Depreciation
-1,564.00
Properties
0.00
Land And Improvements
1,044.00
Buildings And Improvements
100.00
Machinery Furniture Equipment
2,028.00
Construction In Progress
388.00
Other Properties
1.00
Goodwill And Other Intangible Assets
25,613.00
Goodwill
8,127.00
Other Intangible Assets
17,486.00
Other Investments
67.00
Non Current Deferred Assets
Non Current Deferred Taxes Assets
289.00
Other Non Current Assets
37.00
Total Liabilities Net Minority Interest
16,146.00
Current Liabilities
4,933.00
Payables And Accrued Expenses
Payables
3,683.00
Accounts Payable
2,058.00
Other Payable
1,313.00
Current Accrued Expenses
Employee Benefits
Total Tax Payable
312.00
Current Debt And Capital Lease Obligation
836.00
Current Debt
788.00
Other Current Borrowings
Current Capital Lease Obligation
48.00
Current Deferred Liabilities
Current Deferred Revenue
Other Current Liabilities
Total Non Current Liabilities Net Minority Interest
11,213.00
Long Term Debt And Capital Lease Obligation
7,748.00
Long Term Debt
7,663.00
Long Term Capital Lease Obligation
85.00
Long Term Provisions
40.00
Defined Pension Benefit
68.00
Non Current Pension And Other Postretirement Benefit Plans
114.00
Non Current Deferred Liabilities
Non Current Deferred Taxes Liabilities
3,222.00
Other Non Current Liabilities
30.00
Preferred Securities Outside Stock Equity
25.00
Stockholders Equity
16,425.00
Common Stock Equity
16,425.00
Capital Stock
90.00
Common Stock
90.00
Share Issued
8,952.35
Ordinary Shares Number
8,905.31
Treasury Shares Number
47.05
Additional Paid In Capital
2.00
Retained Earnings
27,847.00
Gains Losses Not Affecting Retained Earnings
Treasury Stock
156.00
Minority Interest
59.00
Other Equity Adjustments
Total Equity Gross Minority Interest
16,484.00
Total Capitalization
24,088.00
Working Capital
-383.00
Invested Capital
24,876.00
Total Debt
8,584.00
Net Debt
7,191.00
Capital Lease Obligations
133.00
Net Tangible Assets
-9,188.00
Tangible Book Value
-9,188.00
Available For Sale Securities
Current Provisions
69.00
Derivative Product Liabilities
34.00
Duefrom Related Parties Current
Dueto Related Parties Current
Financial Assets
9.00
Investmentin Financial Assets
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
2,634.00
+14.47%
2,301.00
+9.57%
2,100.00
+1.79%
2,063.00
Cash Flow From Continuing Operating Activities
Net Income From Continuing Operations
1,680.00
+13.90%
1,475.00
+32.76%
1,111.00
-0.71%
1,119.00
Depreciation Amortization Depletion
Depreciation
240.00
+6.67%
225.00
+11.94%
201.00
+11.67%
180.00
Amortization Cash Flow
120.00
+21.21%
99.00
-8.33%
108.00
+0.93%
107.00
Depreciation And Amortization
360.00
+11.11%
324.00
+4.85%
309.00
+7.67%
287.00
Amortization Of Intangibles
Other Non Cash Items
288.00
+0.35%
287.00
-19.61%
357.00
+65.28%
216.00
Pension And Employee Benefit Expense
-73.00
-7400.00%
1.00
-98.57%
70.00
+262.79%
-43.00
Stock Based Compensation
86.00
-15.69%
102.00
+34.21%
76.00
+406.67%
15.00
Asset Impairment Charge
Deferred Tax
472.00
+8.51%
435.00
-15.86%
517.00
+3.61%
499.00
Deferred Income Tax
Operating Gains Losses
Gain Loss On Investment Securities
-43.00
-16.22%
-37.00
Gain Loss On Sale Of PPE
0.00
+100.00%
-7.00
-158.33%
12.00
+140.00%
-30.00
Change In Working Capital
256.00
+24.27%
206.00
+292.52%
-107.00
-159.12%
181.00
Change In Receivables
-65.00
+79.17%
-312.00
-921.05%
38.00
+144.71%
-85.00
Changes In Account Receivables
Change In Inventory
133.00
-38.43%
216.00
+264.89%
-131.00
+55.14%
-292.00
Change In Payables And Accrued Expense
Change In Payable
125.00
-20.89%
158.00
+41.07%
112.00
-71.06%
387.00
Change In Account Payable
Change In Other Working Capital
Change In Other Current Assets
63.00
-56.25%
144.00
+214.29%
-126.00
-173.68%
171.00
Investing Cash Flow
-346.00
-165.53%
528.00
+494.03%
-134.00
+98.47%
-8,784.00
Cash Flow From Continuing Investing Activities
Net PPE Purchase And Sale
-322.00
-28.80%
-250.00
-6.84%
-234.00
+23.03%
-304.00
Purchase Of PPE
-322.00
-28.80%
-250.00
-6.84%
-234.00
+23.03%
-304.00
Sale Of PPE
0.00
0.00
Capital Expenditure
-413.00
-29.87%
-318.00
+5.36%
-336.00
-2.44%
-328.00
Net Investment Purchase And Sale
-6.00
0.00
0.00
-100.00%
700.00
Purchase Of Investment
-6.00
0.00
0.00
Sale Of Investment
0.00
0.00
-100.00%
700.00
Net Business Purchase And Sale
13.00
-97.09%
446.00
+728.17%
-71.00
0.00
Purchase Of Business
0.00
0.00
+100.00%
-71.00
0.00
Gain Loss On Sale Of Business
0.00
+100.00%
-121.00
0.00
0.00
Net Intangibles Purchase And Sale
-91.00
-135.41%
257.00
+78.47%
144.00
+1100.00%
12.00
Purchase Of Intangibles
-91.00
-33.82%
-68.00
+33.33%
-102.00
-325.00%
-24.00
Financing Cash Flow
-3,143.00
-104.49%
-1,537.00
+1.98%
-1,568.00
-122.69%
6,911.00
Cash Flow From Continuing Financing Activities
Net Issuance Payments Of Debt
-1,306.00
-300.31%
652.00
+217.90%
-553.00
-105.83%
9,486.00
Issuance Of Debt
46.00
-96.21%
1,214.00
0.00
-100.00%
11,004.00
Repayment Of Debt
-1,352.00
-140.57%
-562.00
-1.63%
-553.00
+63.57%
-1,518.00
Long Term Debt Issuance
46.00
-96.21%
1,214.00
0.00
-100.00%
11,004.00
Long Term Debt Payments
-1,352.00
-140.57%
-562.00
-1.63%
-553.00
+63.57%
-1,518.00
Net Long Term Debt Issuance
-1,306.00
-300.31%
652.00
+217.90%
-553.00
-105.83%
9,486.00
Net Common Stock Issuance
-654.00
-5.65%
-619.00
0.00
0.00
Common Stock Payments
-654.00
-5.65%
-619.00
0.00
0.00
Common Stock Dividend Paid
-388.00
+85.53%
-2,682.00
Cash Dividends Paid
-612.00
-7.37%
-570.00
-46.91%
-388.00
+85.53%
-2,682.00
Repurchase Of Capital Stock
-654.00
-5.65%
-619.00
0.00
0.00
Net Other Financing Charges
-143.00
+71.46%
-501.00
-355.45%
-110.00
-130.30%
363.00
Changes In Cash
-855.00
-166.18%
1,292.00
+224.62%
398.00
+109.47%
190.00
Effect Of Exchange Rate Changes
-49.00
+37.97%
-79.00
-426.67%
-15.00
-200.00%
15.00
Beginning Cash Position
2,207.00
+122.03%
994.00
+62.68%
611.00
+50.49%
406.00
End Cash Position
1,303.00
-40.96%
2,207.00
+122.03%
994.00
+62.68%
611.00
Free Cash Flow
2,221.00
+12.00%
1,983.00
+12.41%
1,764.00
+1.67%
1,735.00
Interest Paid CFF
-357.00
+0.83%
-360.00
+10.89%
-404.00
-147.85%
-163.00
Interest Received CFI
60.00
-20.00%
75.00
+177.78%
27.00
+42.11%
19.00
Sale Of Business
13.00
-97.09%
446.00
0.00
0.00
Sale Of Intangibles
0.00
-100.00%
325.00
+32.11%
246.00
+583.33%
36.00
Taxes Refund Paid
-439.00
+25.97%
-593.00
-33.26%
-445.00
-37.35%
-324.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category